Insights On Partnering

  1. Why Flexible Payment Options Matter For Clinical Trial Participants 1/15/2026

    In clinical trials, offering a variety of payment options is critical for participant retention and overall study success. How can you make the payment process simple and flexible?

  2. Enhancing Sterility: The Crucial Role Of Isolators In Sterile Fill/Finish 4/17/2024

    Isolators provide a controlled and sterile environment during manufacturing. A CDMO that prioritizes quality, sterility, and compliance can help you deliver the highest level of quality and sterility.

  3. The Place Of PROs In The Future Of Healthcare 3/12/2024

    Discover how integrating Patient-Reported Outcomes can drive alignment with Value-Based Care (VBC) principles, enhancing product marketability and adoption while promoting patient health and quality of life.

  4. Five Questions Biotechs Should Ask Before Selecting A Bioanalytical CRO 9/2/2025

    In a landscape where speed, quality, and trust are inseparable, choosing a CRO that shares your ambition is not optional; it is essential to survival and success.

  5. The Importance Of Cognitive And Pharmacodynamic Testing During FIH Trials 5/9/2025

    Learn how to identify which cognitive and pharmacodynamic tests are required for novel CNS-active drugs and best practices on conducting them during First-In-Human (FIH) trials.

  6. Dysfunctions Of Clinical Trial Vendor Selection And Overcoming Them 10/21/2025

    Vendor selection often fails due to five common dysfunctions. Identifying and addressing them early improves alignment, trust, and trial performance—avoiding costly delays.

  7. Package Design Development Services 4/17/2024

    Our pharmaceutical packaging design department provides insightful packaging design and practical knowledge to deliver differentiated and cost-effective packaging solutions.

  8. De-Risking FIH: Integrated Strategies For Rapid Proof-Of-Concept 12/17/2025

    Proper planning for first-in-human studies is crucial to successful drug development, which requires innovative trial designs and sound CMC strategies to mitigate risk and expedite proof-of-concept.

  9. Optimizing Site Activation To Accelerate Clinical Trials 6/5/2025

    Clinical trial site activation delays are a major bottleneck in drug development, hampering trial timelines and funding flows. To reverse this trend, site-focused solutions are being prioritized.

  10. Best Practices For Internal Quality Audits In Life Sciences 3/14/2025

    Discover why internal quality audits are vital in the life sciences sector to ensure regulatory compliance, mitigate risks, and maintain high standards of product quality and patient safety amidst evolving challenges.